Market capitalization is the total value the stock market puts on a company: its share price multiplied by the number of shares outstanding. Each point here is the share count reported in a filing multiplied by the closing price on that filing date, adjusted for later stock splits, so the history moves when a new filing arrives rather than with each day's trading. A larger market cap means investors collectively value the company more highly; by itself it says nothing about profit or debt. Annual points keep the latest observation in each calendar year.
Orchestra BioMed Holdings, Inc. market cap for the quarter ending 2026-08-06 was $250.04M, a 71.64% increase year-over-year.
Orchestra BioMed Holdings, Inc. market cap for the quarter ending 2026-06-30 was $259.35M, a 149.96% increase year-over-year.
Orchestra BioMed Holdings, Inc. market cap for the quarter ending 2026-05-08 was $241.92M, a 120.01% increase year-over-year.
Orchestra BioMed Holdings, Inc. market cap for the quarter ending 2026-03-31 was $250.35M, a 52.68% increase year-over-year.
Orchestra BioMed Holdings, Inc. market cap for fiscal 2026 was $250.04M.
Orchestra BioMed Holdings, Inc. market cap for fiscal 2025 was $235.55M, a 54.18% increase from fiscal 2024.
Orchestra BioMed Holdings, Inc. market cap for fiscal 2024 was $152.78M, a 53.23% decline from fiscal 2023.
Orchestra BioMed Holdings, Inc. market cap for fiscal 2023 was $326.65M, a 62.13% increase from fiscal 2022.